Publication & Citation Trends
Publications
73 total
Potent efficacy of an NA-targeting antibody against a broad spectrum of H5N1 influenza viruses.
Cited by 0
Semantic Scholar
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells.
Cited by 6
Semantic Scholar
The engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor positive cells leading to activation of HBV-specific T cells OA
Cited by 0
Semantic Scholar
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift PDF
Cited by 1,193
OpenAlex
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 PDF
Cited by 1,010
OpenAlex
Tackling COVID-19 with neutralizing monoclonal antibodies OA
Cited by 18
Semantic Scholar
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody PDF
Cited by 2,128
OpenAlex
Research Topics
SARS-CoV-2 and COVID-19 Research
(50)
Animal Virus Infections Studies
(23)
COVID-19 Clinical Research Studies
(16)
Viral gastroenteritis research and epidemiology
(14)
vaccines and immunoinformatics approaches
(9)
Affiliations
Fleet Science Center
University of California, San Francisco
Washington University in St. Louis
Vir Biotechnology (Switzerland)
Southwestern Medical Center